Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2002
05/23/2002WO2001068565A3 Chemoselective ligation by use of a phosphine
05/23/2002WO2001027077A3 Hydroxysulfonylalkylene-, phosphonoalkylene- or difluoro(phosphononon)methyl- substituted benzene, or benzofuran derivatives as non-peptidic cdc25 inhibitors
05/23/2002US20020062031 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
05/23/2002US20020062028 Process for water soluble azole compounds
05/23/2002US20020062027 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds.
05/23/2002US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
05/23/2002US20020061839 Serine peptidase modulators
05/23/2002US20020061828 Anionic alkoxylate surfactant
05/23/2002DE10056740A1 New polycyclic organic radicals e.g. useful in biochemistry, magnetic materials, electrically conductive materials, superconductors, analysis, oligomers and polymers
05/23/2002CA2429426A1 Isoxazole derivatives
05/23/2002CA2429252A1 Chiral diphosphines and their metal complexes
05/23/2002CA2427207A1 Multipurpose packages for sterilised products or products to be sterilised
05/22/2002EP1207182A1 Flame retardant thermoplastic resin composition
05/22/2002EP1207135A1 Phosphation reagent, process and use
05/22/2002EP1206574A2 Guanidinium functionalized oligomers and methods
05/22/2002EP1206475A1 Transition metal complexes comprising .beta.-diiminate ligands and processes for polymerizing olefins
05/22/2002EP1206429A2 Stilbenes with vascular damaging activity
05/22/2002EP1206427A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
05/22/2002EP1206265A1 Src kinase inhibitor compounds
05/22/2002EP1206260A1 Src kinase inhibitor compounds
05/22/2002EP1169326A4 Process for preparing alendronic acid
05/22/2002EP1042334B1 Acyl phosph(on)ate inhibitors of beta-lactamase
05/22/2002EP0907320B1 Fungicidal compositions
05/22/2002EP0804501B1 Microcapsules containing a stabiliser mixture made from chromane derivatives, inert organic solvents and organic phosphites or phosphonites and/or amines.
05/22/2002EP0576527B1 5-thio-substituted benzotriazole uv-absorbers and stabilized compositions
05/22/2002EP0563238B1 Imidazolyl-alkenoic acids
05/22/2002CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
05/22/2002CN1349996A Methamidophos derivative with low toxicity and its application in pesticide
05/22/2002CN1349995A Preparation method for alkyl methyl acrylate
05/22/2002CN1349994A Diphospholigand with ferrocene modified chiral pocket and its synthesis and application
05/22/2002CN1085213C Triazole derivatives useful in therapy
05/21/2002US6392089 Photoreleasable protecting groups on alcohols, phosphates and diacids and the use thereof
05/21/2002US6392076 Weakly coordinating anions containing polyfluoroalkoxide ligands
05/21/2002US6391926 3,3'-bis(9-anthryl)-1,1'-binaphthyl-2,2'-diol, and 3,3'-bis(9-anthryl)-1,1'-binaphthyl-2,2'-diyl phosphoric acid, asymmetry-identifying agents
05/21/2002US6391912 Pesticides, herbicides
05/21/2002US6391905 4,5-dihydro-8-methylthio-2-phenylfuro(3,4-e)benzothiazole-6-ca rboxylic acid, for example; anti-matrix metalloprotease activity; for bone diseases such as osteoporosis, rheumatoid arthritis, cancer metastasis
05/21/2002US6391866 Analgesics
05/21/2002CA2061699C Pyranyl cyanoguanidine derivatives
05/21/2002CA2059739C Coating compositions
05/21/2002CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same
05/16/2002WO2002038679A1 Cyanine dye phosphoramidites
05/16/2002WO2002038628A2 Substituted pyridyl amine ligands, complexes and catalysts therefrom; processes for producing polyolefins therewith
05/16/2002WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
05/16/2002WO2002038190A2 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
05/16/2002WO2001092272A3 Reaction systems for making n-(phosphonomethyl)glycine compounds
05/16/2002US20020058837 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst
05/16/2002US20020058834 Preparation of N-acyl amino carboxylic acids, amino carboxylic acids and their derivatives by metal-catalyzed carboxymethylation in the presence of a promoter
05/16/2002US20020058814 Process for the preparation of enantiomerically pure (5,5'-dichloro-6,6'-dimethoxy-biphenyl-2,2'-diyl)- bis(diphenylphosphine oxides)
05/16/2002US20020058768 For use in addition polymerization of olefins
05/16/2002US20020058762 For use in homopolymerisation and copolymerisation of olefins; for controlling average molecular weight of polymer produced
05/16/2002US20020058646 Substituted pyridine compounds useful for controlling chemical synaptic transmission
05/16/2002US20020058645 Cyclipostins, process for their preparation and use thereof
05/16/2002US20020058644 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
05/16/2002DE10056310A1 Verbessertes Verfahren zur Herstellung von enantiomerenreinen(5,5`-Dichlor-6,6`-dimethoxybiphenyl-2,2`-diyl)-bis-(diphenylphosphinoxiden) An improved process for the preparation of enantiomerically pure (5,5`-dichloro-6,6`-dimethoxybiphenyl-2,2`-diyl) bis (diphenylphosphinoxiden)
05/16/2002CA2428808A1 Aryl phosphate derivatives of d4t
05/15/2002EP1205998A2 Electrolytes
05/15/2002EP1205486A1 Improved method for the preparation of enantiomerically pure (5,5'-dichloro-6,6'-dimethoxybiphenyl-2,2'-diyl)-bis-(diphenylphosphine oxides)
05/15/2002EP1205485A1 Method for producing polymer materials with reduced fire risk
05/15/2002EP1205484A1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt
05/15/2002EP1205483A1 Method of purifying organic phosphoric ester
05/15/2002EP1204642A1 Fungicides
05/15/2002EP1204626A1 Ether compounds, compositions, and uses thereof
05/15/2002EP1095047A4 Improved preparations of thiophosphites and thiophosphonates
05/15/2002EP1036080B1 Method for producing dialkylphosphinic acid salts
05/15/2002CN1349644A Lubricant for magnetic recording medium and use thereof
05/15/2002CN1349561A Method for producing L-phosphinothricine by enzymatic transamination with aspartate
05/15/2002CN1349517A Cyclocarbamate derivatives as progesterone receptor modulators
05/15/2002CN1084790C Process for mfg. vegetable lysolecithins
05/15/2002CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives
05/15/2002CN1084614C Medicaments
05/14/2002US6388130 Method for producing axial asymmetric compounds, and intermediates for producing the same
05/14/2002US6388125 Process for preparing phosphinic acids
05/14/2002US6388121 Process for the production of phosphor organic compounds
05/14/2002US6388120 Continuous process for the manufacture of phosphoric acid esters
05/14/2002US6388116 Near infrared absorbing compound
05/14/2002US6388098 Process for preparing ascorbic acid-2-monophosphate salt
05/14/2002US6388074 Process for the preparation of purine derivatives
05/14/2002US6387924 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
05/14/2002US6387922 Annulated azole derivatives useful as microbicidal agents
05/14/2002CA2260898C Phosphinate based inhibitors of matrix metalloproteases
05/10/2002WO2002036671A1 Vulcanization accelerator and fluororubber composition for vulcanization
05/10/2002WO2002036557A2 Fluoroborate salts comprising a reactive cation and uses thereof
05/10/2002WO2002016381A3 Composition and method for inhibiting platelet aggregation
05/10/2002WO2002011743B1 Treatment of prostate cancer
05/10/2002WO2001040236A3 Phosphorylation of terminal primary alcohol groups
05/10/2002WO2000053603A9 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents
05/10/2002CA2361205A1 Electrolytes
05/09/2002US20020055653 Diphosphines
05/09/2002US20020055646 Blocked mercaptosilane coupling agents for filled rubbers
05/09/2002US20020055643 Tubulin binding ligands and corresponding prodrug constructs
05/09/2002US20020055600 Olefin polymerization catalysts, transition metal compounds, processes for olefin polymerization, and alpha-olefin/conjugated diene copolymers
05/09/2002US20020055568 3-(acylmercapto)propyltrialkoxy- or trihydroxysilane
05/09/2002US20020055564 Sulfur silane coupling agents which are latent
05/09/2002US20020055181 Light generating compound for use in the detection of preferential particles in sample
05/09/2002US20020055045 Novel materials useful as electrolytic solutes
05/08/2002EP1203999A2 Photoinitiator comprising a borane and an electron donating compound
05/08/2002EP1203773A1 Process for the preparation of alkenylphosphonic acid derivatives
05/08/2002EP1203769A1 Hypolipidemic 1,4-benzothiazepine derivative
05/08/2002EP1203091A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases
05/08/2002EP1203001A1 Tris(oxalato)phosphates, method for their preparation and their use